neurocare Group AG (neurocare), a leader in innovative mental health treatments headquartered in Munich, through its digital therapy platform (DTP), provides holistic and patient centric treatments for a variety of psychological or neurological conditions. It develops, manufactures and distributes non-invasive devices and innovative mental health care methods and tools including sleep assessment, therapeutics, psychotherapy, Transcranial Magnetic Stimulation (TMS) and neurofeedback systems, all supervised within a cloud-based solution, to empower clinicians and deliver individualized care to treat patients with Major Depressive Disorders (MDD). . 

neurocare’s offering is used in the Company’s own clinics in the US, Europe and Australia, as well as in a growing number of third-party clinics.

 

 

Investment date  April 2024 – Read the Deal Announcement
Website https://www.neurocaregroup.com/
Sector Mental Health
Region Global, KSA Market Entry
Investment type Growth

 

Investment Rationale

Globally, 13.0% of people are affected by mental disorders (WHO), causing tremendous direct and indirect costs which are expected to increase from $2.5 trillion in 2010 to $6 trillion by 2030. The number of patients diagnosed with mental illnesses doubled during the COVID pandemic. The treatment of mental health conditions remains nevertheless significantly lacking in most countries, leaving a considerable portion of the population without the necessary support, and presenting a unique growth opportunity for companies like neurocare offering innovative non-invasive treatments with superior clinical outcomes. Together with TVM Capital Healthcare, neurocare will drive its international growth plans, in particular its market expansion into the Kingdom of Saudi Arabia, and the continuous development of innovative treatment methods.

Impact

Access 
  • High demand and limited supply  for mental health treatment in Saudi Arabia 
Quality​
  • Non-invasive treatments with high response rates for drug resistant patients​
  • Continued trainings and qualification programs for TMS treatments and neurofeedback ​

Innovation

  • Bring innovative treatment methods and technology into the Kingdom of Saudi Arabia ​
Future Growth Prospects
  • Operating a chain of clinics across the country​